WWM
MRNA icon

Western Wealth Management’s Moderna MRNA Stock Holding History

Western Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,774
Closed -$211K – 758
2024
Q2 		$211K Buy
+1,774
New +$224K 0.02% 622
2023
Q1 		– Sell
-1,162
Closed -$209K – 658
2022
Q4 		$209K Sell
1,162
-1,179
-50% -$193K 0.02% 564
2022
Q3 		$276K Buy
2,341
+137
+6% +$20.8K 0.02% 657
2022
Q2 		$314K Sell
2,204
-372
-14% -$53.2K 0.02% 596
2022
Q1 		$444K Buy
2,576
+1,380
+115% +$232K 0.02% 562
2021
Q4 		$306K Buy
+1,196
New +$350K 0.03% 465
2021
Q2 		$376K Buy
1,591
+49
+3% +$8.76K 0.04% 426
2021
Q1 		$202K Sell
1,542
-4,546
-75% -$659K 0.03% 499
2020
Q4 		$636K Buy
+6,088
New +$616K 0.09% 216

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Western Wealth Management's MRNA Position: Q3 2024 in Review

Western Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,774 shares — an estimated $211K sold.

Western Wealth Management first reported a position in MRNA in Q4 2020 and held it in 9 quarters. The position peaked at $636K in Q4 2020. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Western Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Western Wealth Management sold 1,774 Moderna shares in Q3 2024, an estimated $211K.
  • Western Wealth Management first reported a position in Moderna in Q4 2020 and held it in 9 quarters.
  • Western Wealth Management's Moderna position peaked at $636K in Q4 2020.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Western Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.